v3.25.3
Share-based payments - Disclosure of reconciliation of BCEs (Details) - shares
9 Months Ended
Sep. 30, 2025
May 14, 2018
Mar. 15, 2018
Nov. 20, 2017
Jan. 23, 2017
Nov. 07, 2016
Sep. 30, 2025
Total BCEs              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of instruments outstanding, beginning balance (in shares)             330,179
Number of instruments issued (in shares) 496,965           0
Number of instruments lapsed (in shares)             0
Number of instruments exercised (in shares)             (24,246)
Number of instruments outstanding, ending balance (in shares) 305,933           305,933
Number of instruments exercisable (in shares) 221,716           221,716
Maximum number of shares to be issued if all conditions are met (in shares) 305,933           305,933
BCE-2016-1              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of instruments outstanding, beginning balance (in shares)             18,796
Number of instruments issued (in shares)           84,000 0
Number of instruments lapsed (in shares)             0
Number of instruments exercised (in shares)             (13,796)
Number of instruments outstanding, ending balance (in shares) 5,000           5,000
Number of instruments exercisable (in shares) 5,000           5,000
Maximum number of shares to be issued if all conditions are met (in shares) 5,000           5,000
BCE-2017-1              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of instruments outstanding, beginning balance (in shares)             67,000
Number of instruments issued (in shares)         67,374   0
Number of instruments lapsed (in shares)             0
Number of instruments exercised (in shares)             0
Number of instruments outstanding, ending balance (in shares) 67,000           67,000
Number of instruments exercisable (in shares) 41,735           41,735
Maximum number of shares to be issued if all conditions are met (in shares) 67,000           67,000
BCE-2017-2              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of instruments outstanding, beginning balance (in shares)             112,500
Number of instruments issued (in shares)       150,000     0
Number of instruments lapsed (in shares)             0
Number of instruments exercised (in shares)             0
Number of instruments outstanding, ending balance (in shares) 112,500           112,500
Number of instruments exercisable (in shares) 112,500           112,500
Maximum number of shares to be issued if all conditions are met (in shares) 112,500           112,500
BCE-2017-4              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of instruments outstanding, beginning balance (in shares)             67,373
Number of instruments issued (in shares)       67,374     0
Number of instruments lapsed (in shares)             0
Number of instruments exercised (in shares)             0
Number of instruments outstanding, ending balance (in shares) 67,373           67,373
Number of instruments exercisable (in shares) 33,686           33,686
Maximum number of shares to be issued if all conditions are met (in shares) 67,373           67,373
BCE-2017-5              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of instruments outstanding, beginning balance (in shares)             33,687
Number of instruments issued (in shares)       67,374     0
Number of instruments lapsed (in shares)             0
Number of instruments exercised (in shares)             0
Number of instruments outstanding, ending balance (in shares) 33,687           33,687
Number of instruments exercisable (in shares) 16,843           16,843
Maximum number of shares to be issued if all conditions are met (in shares) 33,687           33,687
BCE-2018-1              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of instruments outstanding, beginning balance (in shares)             11,980
Number of instruments issued (in shares)     22,000       0
Number of instruments lapsed (in shares)             0
Number of instruments exercised (in shares)             (8,450)
Number of instruments outstanding, ending balance (in shares) 3,530           3,530
Number of instruments exercisable (in shares) 3,530           3,530
Maximum number of shares to be issued if all conditions are met (in shares) 3,530           3,530
BCE-2018-4              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of instruments outstanding, beginning balance (in shares)             16,843
Number of instruments issued (in shares)   16,843         0
Number of instruments lapsed (in shares)             0
Number of instruments exercised (in shares)             0
Number of instruments outstanding, ending balance (in shares) 16,843           16,843
Number of instruments exercisable (in shares) 8,422           8,422
Maximum number of shares to be issued if all conditions are met (in shares) 16,843           16,843
BCE-2018-5              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of instruments outstanding, beginning balance (in shares)             2,000
Number of instruments issued (in shares)   22,000         0
Number of instruments lapsed (in shares)             0
Number of instruments exercised (in shares)             (2,000)
Number of instruments outstanding, ending balance (in shares) 0           0
Number of instruments exercisable (in shares) 0           0
Maximum number of shares to be issued if all conditions are met (in shares) 0           0